Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel biological therapeutic approaches to cutaneous lupus erythematosus.

Expert opinion on biological therapy - 1 Oct 2018

Tayer-Shifman Oshrat E, Rosen Cheryl F, Wakani Laura, Touma Zahi

Abstract excerpt

INTRODUCTION: Cutaneous lupus erythematosus (CLE) encompasses a spectrum of dermatologic manifestations which can occur with or without systemic lupus erythematosus (SLE). Treatment of CLE is challenging as the traditional treatments are off label and often fail and there is no drug specifically approved for CLE. The knowledge gained from the emerging trials on biologic therapy in SLE has provided insight into...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Products
Share to Lupus Erythematosus, Cutaneous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lupus Erythematosus, Systemic

Share to Phenotype

Share to Treatment Outcome

Source

Identifiers

PMID: 30118337
DOI: 10.1080/14712598.2018.1513484

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel biological therapeutic approaches to cutaneous lupus erythematosus.PMID 30118337Read ↗

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosusSemantic proximity Read ↗

A Review of Cutaneous Manifestations of Systemic Lupus Erythematosus in Clinical PracticeSemantic proximity Read ↗

Update on pathogenesis and treatment of CLE.Semantic proximity Read ↗

The Cutaneous Spectrum of Lupus Erythematosus.Semantic proximity Read ↗

Molecular Profiling of Cutaneous Lupus Lesions Identifies Subgroups Distinct from Clinical PhenotypesSemantic proximity Read ↗

Immunogenetics of cutaneous lupus erythematosus.Semantic proximity Read ↗

Pathophysiology of cutaneous lupus erythematosusSemantic proximity Read ↗

Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkersSemantic proximity Read ↗

An update on pathogenesis of systemic lupus erythematosus.Semantic proximity Read ↗

Recent advances in understanding pathogenesis and therapeutic strategies of Systemic Lupus Erythematosus.Semantic proximity Read ↗

The diagnosis and management of the haematologic manifestations of lupus.Semantic proximity Read ↗

Clinical and Immunogenetic Aspects of Systemic Lupus Erythematosus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.